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Abstract
Introduction Preventing perioperative tissue oxygen debt
contributes to a better postoperative recovery. Whether the
beneficial effects of fluids and inotropes during optimization of
the oxygen delivery index (DO2I) in high-risk patients submitted
to major surgeries are due to fluids, to inotropes, or to the
combination of the two is not known. We aimed to investigate
the effect of DO2I optimization with fluids or with fluids and
dobutamine on the 60-day hospital mortality and incidence of
complications.
Methods A randomized and controlled trial was performed in 50
high-risk patients (elderly with coexistent pathologies)
undergoing major elective surgery. Therapy consisted of
pulmonary artery catheter-guided hemodynamic optimization
during the operation and 24 hours postoperatively using either
fluids alone (n = 25) or fluids and dobutamine (n = 25), aiming
to achieve supranormal values (DO2I > 600 ml/minute/m2).
Results The cardiovascular depression was an important
component in the perioperative period in this group of patients.
Cardiovascular complications in the postoperative period
occurred significantly more frequently in the volume group (13/
25, 52%) than in the dobutamine group (4/25, 16%) (relative
risk, 3.25; 95% confidence interval, 1.22–8.60; P < 0.05). The
60-day mortality rates were 28% in the volume group and 8% in
the dobutamine group (relative risk, 3.00; 95% confidence
interval, 0.67–13.46; not significant).
Conclusion In patients with high risk of perioperative death,
pulmonary artery catheter-guided hemodynamic optimization
using dobutamine determines better outcomes, whereas fluids
alone increase the incidence of postoperative complications.
Introduction
Mortality is unacceptably high in certain groups of surgical
patients [1]. Advanced age, extensive surgical trauma, cancer,
blood transfusions, and poor nutritional state are conditions
reported to be associated with severe changes of the body's
defense mechanisms, making the patient highly susceptible to
morbidity and mortality [2-4]. Sepsis and multiple organ failure
remains the most common cause of death [5].
Some authors have shown that the optimization of the oxygen
delivery index (DO2I > 600 ml/minute/m2), guided by a pulmo-
nary artery catheter, in the perioperative period of high-risk
patients determined better survival and less episodes of com-
plications when initiated before the development of organ fail-
ure and when therapy produced differences in oxygen delivery
[5-11]. The term 'optimization' refers to therapeutic interven-
tion mainly with fluids, inotropic drugs and red blood cells, aim-
CI = confidence interval; DO2I = oxygen delivery index; FiO2 = fraction of inspired oxygen; ICU = intensive care unit; LVSWI = left ventricular stroke 
work index; MAP = mean arterial pressure; PaCO2 = partial pressure of carbon dioxide; PaO2 = partial pressure of oxygen; PAOP = pulmonary artery 
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ing at a better cardiovascular function anticipating the
increase in oxygen demand during surgery. The main objective
is to maintain tissue perfusion to minimize the hepatosplanch-
nic ischemia, thus assuring organic function.
High-risk surgical patients often present a decreased intravas-
cular volume prior to a surgical procedure due to various fac-
tors. The importance of fluid replacement in the perioperative
period cannot be underestimated [12]. Anesthetic induction
still results in increases in systemic vascular capacitance and,
to a certain extent, in myocardial depression. Patients with
chronic heart failure can face a series of events during pro-
longed surgery that may end in acute decompensation. Even
critically ill patients without preexisting myocardial contractile
dysfunction may sustain severe perioperative complications
with subsequent acute heart failure [13].
In previous randomized controlled trials in high-risk surgical
patients, after the adequate recovery of volemia, either dob-
utamine or dopexamine have been used with the objective to
optimize the cardiac index and/or the oxygen delivery [6-10].
Older patients with existing cardiorespiratory illness undergo-
ing major surgery have a reduced morbidity and mortality when
dobutamine is used to maximize oxygen transport [10]. Never-
theless, in certain groups of surgical patients, goal-directed
therapy using fluids alone improved the outcome [14-17]. Evi-
dence that optimization of fluid therapy, in the absence of ino-
tropes, reduces mortality in high-risk patients is not available.
The primary outcome measure of the present study was to
evaluate the effect of both DO2I optimization with fluids or with
fluids and dobutamine on the 60-day mortality in high-risk gen-
eral surgery patients. The second outcome measure was the
incidence of complications, particularly cardiovascular
adverse events.
Materials and methods
This study, approved by the Institutional Review Board, was
carried out in the operating room and the intensive care unit
(ICU) (24 beds) of a tertiary hospital. The informed consent to
take part in the study was obtained from the patient or from
their closest relative. Patients undergoing elective surgeries
were admitted to the study if they assigned ≥ 3 points accord-
ing to a risk scoring system (Table 1) adapted from American
College of Cardiology/American Heart Association guidelines
[18]. The exclusion criteria were refusal of consent, hemody-
namic instability prior to surgery, congestive heart failure, pres-
ence of infection, acute myocardial ischemia prior to
enrolment, life expectancy lower than 60 days, and dissemi-
nated malignancy.
Measurements of hemodynamic and oxygenation 
variables
The electrocardiograph, pulse oxymetry and mean arterial
pressure (MAP) were monitored continuously during the study
period. A pulmonary artery catheter was introduced prior to
surgery in the ICU or in the operating room (Balloon Thermodi-
lution Catheter, 7 F, 3 lumen TD, Arrow F; Arrow International,
Inc., Reading, PA, USA) and mixed venous blood samples
(pulmonary artery) were taken for analysis of the pH, PaO2,
PaCO2, arterial oxygen saturation, mixed venous oxygen 
Table 1
Risk scoring system (adapted from American College of Cardiology/American Heart Association guidelines)
Score Risk factor
High-risk surgery (1 point) Gastrectomy
Pancreatectomy
Total colectomy
Total esophagectomy
Another long surgical procedure associated with large fluid shifts or blood losses
Minor clinical predictor (1 point) Diabetes (defined as standard taking medication or not)
Abnormal electrocardiogram (left ventricular hypertrophy, left bundle-branch block, ST-T 
abnormalities, atrial fibrillation)
Low functional capacity (inability to climb one flight of stairs with a bag of groceries)
Arrhythmia (using drugs)
History of stroke
Arterial hypertension (Difficult controlling).
Intermediate clinical predictor (2 points) Age (>60 years)
Angina (class I or II, Canadian Cardiovascular Society Classification) or previous infarctus or Q 
waves
Compensated or previous decompensated heart failure (defined as standard)
Chronic hepatic failure (defined as standard)
Chronic renal failure (preoperative creatinine > 2.0 mg/dl or need for dialysis)
Chronic obstructive pulmonary disease (defined as standard) or severe respiratory illness 
resulting in functional limitation
Major clinical predictor (3 points) Angina (class III or IV, Canadian Cardiovascular Society Classification) Severe arrhythmias 
(advanced heart block, ventricular arrhythmia in the presence of cardiopathy or 
supraventricular arrhythmia with tachycardia) Severe valvopathy (severe valvular regurgitation 
with reduced left ventricular function)Available online http://ccforum.com/content/10/3/R72
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saturation, hematocrit and hemoglobin levels, and lactate
(OMNI Modular System AVL Roswell, GA, USA). Cardiac out-
put measurements were obtained using thermodilution meth-
ods as previously described [10]. Measurements of the
cardiac index, pulmonary artery occlusion pressure (PAOP)
and mixed venous and arterial blood gas were obtained
directly each hour during the surgery and each 4 hours after
admission to the ICU during 24 hours; the other variables were
calculated according to standard formulae. The maximum
PAOP was defined as the higher value of PAOP obtained dur-
ing surgery and 24 hours postoperatively.
Management
The patients were randomized with the use of sealed enve-
lopes (blocks of 10 patients) to either the volume group or the
dobutamine group. To induce and maintain anesthesia the fol-
lowing drugs were used: midazolam, 0.05–0.10 mg/kg; etomi-
date, 0.3 mg/kg; sufentanil, 1 µg/kg (maintenance, 0.01 µg/
kg/minute); atracurium, 0.5 mg/kg (maintenance, 0–10 µg/kg/
minute); and isoflurane. The therapeutic goals were the same
in both groups: maintenance of DO2I > 600 ml/minute/m2,
MAP between 70 and 110 mmHg, PAOP between 12 and 16
mmHg, hematocrit > 30%, arterial oxygen saturation > 94%,
and urinary output > 0.5 ml/kg/hour.
The patients randomly selected for the volume group were
treated with fluids according to the treatment algorithm (Figure
1). The patients randomized to the dobutamine group received
the first fluid cycle during 60–90 minutes followed by increas-
ing doses of dobutamine, beginning with 3 µg/kg/minute, until
the goal was reached. The patient should receive a new fluid
cycle if the PAOP decreased for less than 12 mmHg or if there
was a strong clinical suspicion of hypovolemia.
The heart rate, rhythm and MAP were carefully monitored and
the dose of dobutamine was decreased or interrupted in the
case of hypotension (MAP < 70 mmHg) and/or in the pres-
ence of signs of myocardial ischemia (depressed ST segment
or inexplicable hypotension or tachycardia). The Acute Physi-
ology and Chronic Health Evaluation II scores were calculated
Figure 1
Treatment algorithm Treatment algorithm. MAP, mean arterial pressure; PAOP, pulmonary artery occlusion pressure; Ht, hematocrit; SaO2, arterial oxygen saturation; 
DO2I, oxygen delivery index; RBC, red blood cells; CI, cardiac index.Critical Care    Vol 10 No 3    Lobo et al.
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after admission to the ICU [19]. The C-reactive protein serum
level (nephelometry) was evaluated after surgery as a marker
of inflammation. The dobutamine infusion was maintained for
24 hours in the postoperative period and then was slowly
reduced until complete interruption. The mechanical ventila-
tion and weaning were performed according to the ICU rou-
tine. Fentanyl and midazolam were used for sedation and
analgesia.
Outcome
The patient was defined as an achiever when DO2I > 600 ml/
minute/m2 was attained for at least one time point. Patients
were followed up for 60 days. Diagnosis of complications was
based on predefined criteria. Acute heart failure was desig-
nated by the presence of signs of myocardial dysfunction with
PAOP > 18 mmHg and cardiac index < 2.2 l/minute/m2. Pul-
monary edema was considered in the presence of radiological
signs of pulmonary edema along with PAOP > 18 mmHg and
clinical repercussion leading to prolonged mechanical ventila-
tion/ICU stay or reintubation. Acute myocardial infarction was
considered in the presence of electrocardiographic signs of
ischemia with an increase of cardiac enzymes and/or segmen-
tal changes in the echocardiogram. Arrhythmia was consid-
ered when a different cardiac rhythm with hemodynamic
repercussions or a need for anti-arrhythmic drugs was
recorded. Mesenteric infarction due to acute insufficiency of
the splanchnic blood flow was designated by direct visualiza-
tion during emergent surgery.
Postoperative bleeding was defined as the presence of bleed-
ing requiring new surgical exploration or the transfusion of
more than 2 units blood derivatives. Gastrointestinal bleeding
was considered as standard. Acute renal failure was defined
as an increase greater then two times in the creatinine serum
level in the postoperative period in patients with previous nor-
mal renal function. Acute respiratory failure was defined as a
PaO2/FiO2 ratio ≤ 200 mmHg and PAOP < 18 mmHg and a
need for invasive or non-invasive mechanical ventilation. For
Table 2
Baseline characteristics of patients in the volume group and the dobutamine group
Volume group Dobutamine group
Number of patients 25 25
Male (%) 69 76
Age 69.9 ± 8.4 67.6 ± 7.5
Acute Physiology and Chronic Health Evaluation II score 14.4 ± 6.2 12.4 ± 6.5
Risk Scoring System (points) 4.25 ± 1.22 4.44 ± 1.53
Aged > 60 years 23 (92%) 20 (80%)
Cancer 24 (96%) 25 (100%)
Arterial hypertension 16 (64%) 13 (52%)
Coronary artery disease 6 (24%) 5 (20%)
Diabetes mellitus 5 (20%) 2 (8%)
Chronic obstructive pulmonary disease 4 (16%) 0 (0%)
Arrhythmia 3 (12%) 2 (8%)
Cerebral vascular accident 1 (4%) 0 (0%)
Compensated heart failure 2 (8%) 3 (12%)
Chronic renal failure 0 (0%) 1 (4%)
Type of surgery
Colorectal 9 5
Hepatobiliary 1 1
Duodenopancreatectomy 2 5
Esofagectomy 1 3
Gastrectomy 6 5
Urology 5 4
Other 1 2Available online http://ccforum.com/content/10/3/R72
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nosocomial infections, Centers for Disease Control definitions
were used [20]. Postoperative fistulas and dehiscence of
anastomosis were determined by visualizing the elimination of
intestinal content via drain, wound, or abnormal orifice and by
dehiscence of the surgical wound when there is a superficial
or deep opening of the wound. The diagnosis of severe sepsis
and septic shock were defined according to the American Col-
lege of Chest Physicians/Society of Critical Care Medicine
[21]. An investigator who was unaware of patient allocation by
analyzing medical records as well as all radiological and labo-
ratory investigations undertook evaluation of complications
retrospectively.
Statistical analysis
The size of the sample was based on 60-day inhospital mortal-
ity rates estimated at 40% for the volume group and 15% for
the dobutamine group (assuming that optimization with fluids
alone would be the same as no optimization) [6,10]. To have a
study power of 80% and a two-sided test with a significance
of 0.05, 49 patients would be required in each group. The first
statistical evaluation was to be performed when 50% of the
patients were enrolled to seek differences either on primary
outcomes or on second outcomes. At this point, statistically
significant differences were found in major outcomes. It was
thought unethical to continue and the study was terminated.
Continuous variables were compared with Student's t test.
Analysis of variance was used for repeated measurements.
When there were significant statistical differences the Bonfer-
roni test was used to detect at which moment the differences
occurred. The incidence of complications and mortality rates
were evaluated with the relative risk (RR) (95% confidence
interval (CI)). P < 0.05 was considered statistically significant.
Results
Over an 18-month period (from May 2002 to July 2004) there
were 594 admissions of patients undergoing surgery for post-
operative care in the ICU, and 432 of these were elective sur-
geries. A total of 72 patients (16.5%) were recognized as
fulfilling the entrance criteria and 51 patients were enrolled
into the study. Twenty-one patients were not enrolled; two
because of patient refusal and 19 due to logistic reasons (for
example, unavailability of an ICU bed or a theater room, the
attending physician's refusal). One patient then had the
planned surgical procedure changed to a palliative surgery
due to disseminated malignancy and was withdrawn. Fifty
patients completed the study: 25 in the volume group and 25
in the dobutamine group.
The demographic data of the patients are presented in Table
2. The therapeutic interventions and perfusion variables are
presented in Table 3. In the first 24 hours after ICU admission,
the patients in the volume group received significantly more
red blood cells than those in dobutamine group (1064 ± 684
ml versus 650 ± 226 ml, respectively; P < 0.05). In the volume
group, two patients received dobutamine intraoperatively and
six patients received dobutamine postoperatively due to a car-
diac index lower than 2.5 l/minute/m2 according to the treat-
ment algorithm. Dobutamine was discontinued in five patients
in the dobutamine group in the postoperative period either due
to tachycardia or arterial hypertension. The percentage of
goal-achievers intraoperatively was 28% in the volume group
Figure 2
Oxygen delivery index during surgery and postoperatively Oxygen delivery index during surgery and postoperatively. Oxygen delivery index (DO2I) during surgery and postoperatively for the volume group (● ) 
and the dobutamine group (■ ). *P < 0.05 versus volume group, #P < 0.05 versus baseline. Results presented as the mean and standard error or the 
mean. 0, preoperative; 1, 30 min intraoperatively; 2, 2 hours intraoperatively; 3, 4 hours intraoperatively; 4, 6 hours intraoperatively; 5, 8 hours intra-
operatively; 6, 0 hours postoperatively; 7, 4 hours postoperatively; 8, 8 hours postoperatively; 10, 12 hours postoperatively; 11, 16 hours postoper-
atively; 12, 24 hours postoperatively.Critical Care    Vol 10 No 3    Lobo et al.
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(7/25) in comparison with 84% in the dobutamine group (21/
25) (RR = 0.33, 95% CI = 0.17–0.63). In the ICU, significantly
less patients in the volume group (16/25, 64%) than in the
dobutamine group (22/25, 88%) were goal-achievers (RR =
0.73; 95% CI = 0.52–1.00). At the end of the optimization
therapy there were 76% achievers in the volume group (19/
25) and 96% in the dobutamine group (24/25) (RR = 0.79,
95% CI = 0.62–1.00).
Figure 2 shows the temporal pattern of the DO2I during sur-
gery and postoperatively for the volume and dobutamine
groups. An important DO2I reduction was seen after the start
of anesthesia in both groups. While a recovery was seen in the
dobutamine group, however, the DO2I remained significantly
lower in the volume group in comparison with baseline, with a
statistically significance difference at 4 and 6 hours intraoper-
atively and at 0, 4, 8, 12 and 16 hours postoperatively (P <
0.05 for all). The dobutamine group had a significantly higher
DO2I than the volume group during surgery (at 4 hours, 695 ±
176 versus 485 ± 134 ml/minute/m2; at 6 hours, 703 ± 99
versus 474 ± 134 ml/minute/m2; dobutamine group versus
volume group, P < 0.05 for both) and postoperatively (at 0
hours, 500 ± 151 versus 410 ± 113 ml/minute/m2; at 4 hours,
580 ± 204 versus 463 ± 122 ml/minute/m2; at 8 hours, 593
± 172 versus 485 ± 144 ml/minute/m2; dobutamine group
versus volume group, P < 0.05 for all).
The temporal patterns of the cardiac index, left ventricular
stroke work index (LVSWI) and PAOP during surgery and
postoperatively are presented in Table 4. The LVSWI signifi-
cantly decreased in both groups during the operation and was
significantly lower in the volume group (41 ± 13 g/m/m2) than
in the dobutamine group (48 ± 9 g/m/m2) at 4 hours. The lev-
els of PAOP were significantly higher in the volume group at 6
Table 3
Therapeutic interventions and changes in perfusion variables during optimization
Volume group Dobutamine group
Intraoperatively
Operation time (min) 315 ± 109 331 ± 132
Total volume (l/hour) 1.31 ± 0.54 (0.97/1.21/1.54) 1.35 ± 0.43 (1.05/1.29/1.65)
Red blood cells (ml) 609 ± 244 (480/600/600) 713 ± 458 (500/600/650)
Number of transfused patients (%) 11 (44%) 12 (48%)
Dobutamine doses (µg/kg/minute) 3.5 ± 0.7 5.5 ± 1.8
Dobutamine (number of patients) 2 (8%) 25 (100%)*
Initial serum lactate (mEq/l) 1.3 ± 0.6 1.3 ± 0.5
Final serum lactate (mEq/l) 1.7 ± 0.7 1.9 ± 0.9
Initial mixed venous oxygen saturation 83 ± 4 81 ± 6
Final mixed venous oxygen saturation 86 ± 4 86 ± 7
Number of goal-achievers 7 (28%) 21 (84%)*
Intensive care unit
Total volume (l/hours) 0.29 ± 0.12 0.28 ± 0.18
Red blood cells (ml) 1064 ± 684 (450/600/900) 650 ± 226* (600/600/600)
Number of transfused patients (%) 7 (28%) 6 (24%)
Dobutamine doses (µg/kg/minute) 5.7 ± 2.3 6.1 ± 3.4
Dobutamine (number of patients) 6 (24%) 20 (80%)*
Sodium nitroprusside 6 (24%) 2 (8%)
Initial serum lactate (mEq/l) 2.5 ± 1.6 2.2 ± 0.8
Final serum lactate (mEq/l) 1.9 ± 2.0 1.3 ± 0.4
Initial mixed venous oxygen saturation 76 ± 13 78 ± 9
Final mixed venous oxygen saturation 78 ± 9 77 ± 8
Number of goal-achievers 16 (64%) 22 (88%)*
Data presented as the absolute value (%) or as the mean ± standard deviation. *P < 0.05 versus volume group.Available online http://ccforum.com/content/10/3/R72
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hours postoperatively in comparison with the dobutamine
group (11 ± 3.3 versus 8 ± 1.6 mmHg, P < 0.05). The maxi-
mum PAOP was significantly higher in the volume group than
in the dobutamine group, both intraoperatively and postopera-
tively (14.4 ± 3.8 versus 12.4 ± 2.9 mmHg and 16.0 ± 3.1 ver-
sus 14.1 ± 3.4 mmHg, respectively; P < 0.05).
Postoperative complications
Cardiovascular complications in the postoperative period
occurred significantly more frequently in the volume group
(13/25, 52%) than in the dobutamine group (4/25, 16%) (RR
= 3.25, 95% CI = 1.22–8.60) (Table 5). The prevalence of
infection was similar in both groups (volume group, 28%; dob-
utamine group, 48%; not significant). Complications occurred
in 74% of the achievers in the volume group (14/19) and in
58% of the achievers in the dobutamine group (14/24) (not
significant).
Mortality
There were no significant differences in 28-day or 60-day mor-
tality. The 28-day mortality rates were 20% in the volume
group and 8% in the dobutamine group. The 60-day mortality
rates were 28% in volume group and 8% in dobutamine group
(RR = 3.0, 95% CI = 0.67–13.46).
Discussion
Fluids improve morbidity and mortality when combined with
inotropes during major surgeries. Randomized controlled trials
evaluated the effect of perioperative optimization on mortality
in high-risk surgical patients using either dobutamine or dopex-
amine to improve the DO2I [6-10]. These studies did not inves-
tigate the effects of fluids alone. In the present study there was
a significant reduction in postoperative complications, particu-
larly cardiovascular complications, and a nonsignificant reduc-
tion in mortality in the group optimized with dobutamine and
fluids in comparison with the group optimized with fluids alone.
Nevertheless, significantly more patients in the dobutamine
group were goal-achievers, suggesting an important role of
the inotrope in the optimization therapy in this group of high-
risk patients submitted to elective surgeries.
Unexpectedly, despite the use of two different treatment algo-
rithms driven to obtain a DO2I > 600 ml/minute/m2, both
groups had received similar amounts of fluids at the end of the
Table 4
Hemodynamic and perfusion variables during surgery and postoperatively
0 1 2 3 4 5 6 7 8 9 10 11 12
Cardiac index (l/
minute/m2)
Volume group 3.6/1.1 
(25)
3.2/1.1 
(25)
3.3/0.8 
(22)
3.5/0.6 
(15)
3.4/0.8 
(13)
3.9/0.8 (4) 2.5/0.7 2.9/0.8 3.1/0.9 3.2/0.8 3.5/0.9 3.8/1.2 3.7/0.6
Dobutamine group 3.4/0.7 
(25)
3.0/0.8 
(25)
4.0/1.0*# 
(22)
4.6/1.2* # 
(13)
4.5/0.5* # 
(10)
4.6/0.7# 
(8)
3.0/0.9* 3.6/1.0* 3.8/1.0* 3.9/0.8* 
#
3.9/0.7# 4.0/0.8# 4.0/0.9#
Left ventricular stroke 
work index (g/m/m2)
Volume group 65/22 (25) 43/12# 
(25)
43/12# 
(22)
41/13# 
(15)
46/12# 
(10)
45/11 (4) 37/13# 37/15# 41/23# 42/28# 46/18# 45/22# 42/18#
Dobutamine group 58/15 (25) 43/13# 
(25)
49/17 (22) 48/9* # 
(13)
50/14 (10) 49/18 (8) 39/18# 43/20# 41/19# 42/21# 41/20# 43/17# 42/16#
Pulmonary artery 
occlusion pressure 
(mmHg)
Volume group 12/4.3 
(25)
12/4.3 
(25)
10/3.0 
(22)
10/3.0 
(14)
11/3.3 
(12)
8/1.1 (3) 9/4.1 11/4.7 13/4.5 11/4.6 12/3.5 12/3.3 12/3.9
Dobutamine group 11/4.0 
(25)
12/3.3 
(25)
10/2.9 
(22)
9/2.5 (13) 8/1.6* # 
(10)
10/1.1 (8) 9/3.3 10/3.9 11/3.5 11/4.4 11/4.4 11/3.7 12/3.3
Lactate (mEq/l)
Volume group 1.3/0.6 1.3/0.6 1.2/0.5 1.7/0.6 2.5/1.6 2.8/2.0 2.5/1.6 2.8/1.9 2.0/1.9 2.2/2.0 2.1/2.4 1.9/1.8 1.9/2.0
Dobutamine group 1.3/0.5 1.4/0.8 1.9/0.6 1.2/0.4 2.2/0.8 1.9/0.8 2.2/0.8 1.9/0.8 1.6/0.6 1.6/0.8 1.7/0.8 1.3/0.8 1.3/0.4
Mixed venous oxygen 
saturation (%)
Volume group 83/4 - 86/3 86/5 86/5 86/2 76/13 73/11 76/15 77/10 77/10 77/11 78/9
Dobutamine group 81/6 - 86/2 87/5 85/6 83/11 78/9 80/10 80/9 77/11 79/7 77/8 77/8
Results presented as mean/standard deviation. 0, preoperative; 1, 30 minutes intraoperatively; 2, 2 hours intraoperatively; 3, 4 hours 
intraoperatively; 4, 6 hours intraoperatively; 5, 8 hours intraoperatively; 6, 0 hours postoperatively; 7, 4 hours postoperatively; 8, 8 hours 
postoperatively; 10, 12 hours postoperatively; 11, 16 hours postoperatively; 12, 24 hours postoperatively. *P < 0.05 versus volume group, #P < 
0.05 versus baseline.Critical Care    Vol 10 No 3    Lobo et al.
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optimization therapy. The presence of decreasing values of the
LVSWI suggests contractility problems in both groups. A bet-
ter recovery of the LVSWI was seen in the dobutamine group
during the operative trauma. By counteracting the adverse
events of the fluids, dobutamine probably made a more gener-
ous fluid infusion possible alongside fewer complications in
this group. In contrast, significantly higher values of the maxi-
mum PAOP in response to fluid challenges suggested that
poor cardiovascular reserves limited the fluid infusion in the
volume group.
The mechanism of the protective effect of dobutamine is still
not completely elucidated. Impaired tissue perfusion due to
hypovolemia, disturbed vasoregulation, and myocardial dys-
Table 5
Outcome
Volume group Dobutamine group
Cardiovascular complications
Acute heart failure 2 0
Pulmonary edema 8 3
Acute myocardial infarction 0 1
Cardiac arrhythmia 2 0
Mesenteric infarction 1 0
Number of patients with cardiovascular 
complications (%)
13 (52%) 4 (16%)*
Infectious complications
Pneumonia 5 7
Peritonitis 3 3
Urinary tract infection 1 2
Fistula 1 2
Severe sepsis/septic shock 7 4
Number of patients with infectious 
complications (%)
7 (28%) 12 (48%)
Other complications
Postoperative bleeding 1 0
Upper gastrointestinal bleeding 0 1
Acute renal failure 3 1
Acute respiratory failure 5 2
Number of patients with other 
complications (%)
9 (36%) 4 (16%)
Total number of complications 39 26
Number of patients with complications (%) 17(68%) 14(56%)
Number of achievers with complications 
(%)
14 (74%) 14 (58%)
C-reactive protein on day 1 (mg/dl) 18 (11-23) 13 (10-18)
Median duration of intensive care unit stay 
(days)
3 (2.0-6.0) 3(3.0-8.5)
Median duration of hospital stay (days) 14 (8.5-8.5) 20 (14.5-32)
Mortality rate
28 days 5 (20%) 2 (8%)
60 days 7 (28%) 2 (8%)
Data presented as the absolute value (%) or as the median (interquartile range). *P < 0.05 versus volume group.Available online http://ccforum.com/content/10/3/R72
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function contributes to multiple organ dysfunctions that can be
prevented by the prompt compensation of the oxygen debt by
maintaining supranormal values intraoperatively and in the very
early postoperative period [6,10,22,23]. Significantly, more
patients were achievers in the dobutamine group than in the
volume group, especially in the intraoperative period. If ther-
apy-induced differences in oxygen delivery determine better
outcomes, then our results suggest that the use of inotropes
is necessary during the optimization therapy in this group of
high-risk patients [11]. It is also possible that some beneficial
effects observed were related to inotropes' therapy effects in
regulating inflammation. Higher levels of C-reactive protein, an
inflammation marker, have been detected in volume group;
however, the study was precociously terminated and the
results were not statistically significant [24]. Nevertheless,
dobutamine improves microcirculatory perfusion and
increases splanchnic blood flow, which could prevent more
inflammation secondary to the tissue hypoxia and to the trans-
location of bacterial products or endotoxin [25,26].
The hospital stay was slightly longer in the dobutamine group
despite the fact that the complications and mortality rates
were lower in this group. Other authors reported a significant
reduction in hospital stay mainly due to the reduction of post-
operative infection with postoperative goal-directed therapy
using dopexamine to attain a DO2I > 600 ml/minute/m2 – a
finding different from the present study [23]. The choice of ino-
trope may play a role. Dopexamine may confer an additional
advantage to fluid optimization by reducing the effect of infec-
tive complications. In different studies on optimization, both
inotropes (dobutamine and dopexamine) produced the
desired preoperative increase in oxygen delivery. Only dopex-
amine, however, seems to reduce the hospital stay and infec-
tious complications.
Several potential limitations in our study require comment.
First, blinding was not possible for evaluating outcome and
there was a small imbalance in comorbidities that could deter-
mine case-mix differences between groups.
Second, the volume group received about two times more
packed red blood cells than the dobutamine group. It is prob-
able that this group needed more transfusions due to either
the presence of defective tissue perfusion signs or to differ-
ences in blood losses between groups [27]. Transfusion of
blood derivatives is an independent risk factor for worse out-
come [28]. The complications related to the transfusion of
blood derivatives are infectious most of the time, however,
which in fact did not occur in the present study.
Third, it is possible that the therapeutic approach in the volume
group was not aggressive enough once many patients failed
to achieve the targeted DO2I levels. Indeed, the PAOP was
between 8 and 13 mmHg, although the algorithm suggested
that it had to be pushed up to 16 mmHg. The significantly
higher values of maximum PAOP seen in this volume group,
however, suggest the presence of a poor cardiovascular
reserve limiting fluid challenge more than the presence of
hypovolemia.
Finally, it is possible that the sample size calculation of 40%
mortality rate for this population of elective high-risk surgery
patients was overestimated and the study was underpowered.
We believe, however, that the association of a median of four
risk surgery criteria determines a higher risk population than
those reported by other authors [7-9,29].
Fluid optimization alone reduced complications and improved
recovery times in certain groups of surgical patients [14-16].
Associations between postoperative fluid overload and poor
survival have been shown in other studies, however, and better
outcomes after restrictive fluid resuscitation regimens after
surgery were reported [30-32]. The numbers of cardiopulmo-
nary and tissue-healing complications were significantly
reduced when a restricted fluid regimen in the perioperative
period was used in a randomized multicenter trial after color-
ectal surgery [30]. Another prospective study comparing the
use of restrictive versus liberal fluid management on postoper-
ative outcome in patients undergoing elective intraabdominal
surgery showed less complications in the restrictive group
than in liberal group [31]. We must consider, however, that
these studies have been carried out in groups of less severely
ill patients and with better cardiovascular reserve. Further-
more, different therapeutic regimens and patient populations
make the comparison of these studies difficult.
The cardiovascular depression was an important component
of the hemodynamic response in the perioperative period in
this group of patients. The reductions observed in the DO2I
and in the myocardial contractility evaluated by the LVSWI
were dramatic, especially at two important points of the peri-
operative period: after the induction of anesthesia and after
transport to the ICU. These findings suggest that special
attention should be directed to the hemodynamic support at
these moments. In addition, patient safety may be enhanced
by increasing the use of beta-blockers in high-risk patients and
perioperative treatment with beta-blockers is now widely advo-
cated [33]. Up to now, the hemodynamic effect of beta-block-
ing agents on dobutamine infusion has been controversial
[34,35]. In addition, the best fluid replacement therapy, either
restrictive or liberal in association with an inotrope, must be
the subject of future studies.
Conclusion
Pulmonary artery catheter-guided hemodynamic optimization
using dobutamine determines better outcomes, whereas fluids
alone increase the incidence of postoperative complications in
patients with high risk of perioperative death.Critical Care    Vol 10 No 3    Lobo et al.
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